Evidence map›Paper›PMID 33865834›Full record

ReviewChest2021

Impaired Respiratory Health and Life Course Transitions From Health to Chronic Lung Disease.

Gabrielle Y Liu, Ravi Kalhan

Open access · greenAbstract readReview
In one paragraph

Review in Chest, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Progenitor Resilience and the Early Onset of Chronic Lung Diseases: NHLBI workshop report.American journal of respiratory cell and molecular biology · 2026
    Article
  6. Article
  7. Article
  8. Respiratory injuries among California career firefighters, 2000-2019.Annals of the American Thoracic Society · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Airway Mucus Plugs in Community-Living Adults: A Study Protocol.medRxiv : the preprint server for health sciences · 2024
    Article
  14. Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study.American journal of respiratory and critical care medicine · 2024
    Article
  15. Article
  16. Article
  17. Airway Mucus Plugs in Community-Living Adults: A Study Protocol.Journal of clinical & experimental pathology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Gabrielle Y LiuDivision of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Department of Preventative Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Electronic address: gabrielle.liu@northwestern.edu.
Ravi KalhanDepartment of Preventative Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
Northwestern University · US

Funding

The American Lung Association (ALA) Lung Health CohortU01HL146408 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CARNETHON, MERCEDES RENEE, KALHAN, RAVI · 2019 to 2024
$25.2M
Transitions from Impaired Respiratory Health to Lung DiseaseR01HL122477 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAVI KALHAN · 2014 to 2026
$17.3M
Training Program In Lung SciencesT32HL076139 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KAREN M RIDGE, Jacob I Sznajder · 2004 to 2026
$9.6M
ADalimumab Vs. conventional ImmunoSupprEssion for uveitis(ADVISE) TrialUG1EY028091 · NEI · JOHNS HOPKINS UNIVERSITY · PI HOLBROOK, JANET T., SUGAR, ELIZABETH ANN · 2018 to 2022
$9.0M
Understanding the interstitial phenotype of impaired respiratory health through CT imaging and blood biomarkersF32HL162318 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LIU, GABRIELLE · 2022 to 2023
$117k
NEI NIH HHS UG1 EY028091NHLBI NIH HHS F32 HL162318NHLBI NIH HHS R01 HL122477NHLBI NIH HHS T32 HL076139NHLBI NIH HHS U01 HL146408
6 · The paper itself

Abstract

Primary prevention and interception of chronic lung disease are essential in the effort to reduce the morbidity and mortality caused by respiratory conditions. In this review, we apply a life course approach that examines exposures across the life span to identify risk factors that are associated with not only chronic lung disease but also an intermediate phenotype between ideal lung health and lung disease, termed "impaired respiratory health." Notably, risk factors such as exposure to tobacco smoke and air pollution, as well as obesity and physical fitness, affect respiratory health across the life course by being associated with both abnormal lung growth and lung function decline. We then discuss the importance of disease interception and identifying those at highest risk of developing chronic lung disease. This work begins with understanding and detecting impaired respiratory health, and we review several promising molecular biomarkers, predictive symptoms, and early imaging findings that may lead to a better understanding of this intermediate phenotype.

Indexed as

Lung DiseasesAsymptomatic DiseasesBiomarkersCausalityChronic DiseaseHumansLife Course PerspectiveLife StyleRisk FactorsBiomarkersbiomarkersCOPDinterstitial lung diseaselung health

Identifiers

PMID33865834
PMCPMC8449011
OpenAlexW3153639970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.